STABILE, ARMANDO
 Distribuzione geografica
Continente #
EU - Europa 3.798
NA - Nord America 1.898
AS - Asia 1.432
SA - Sud America 266
Continente sconosciuto - Info sul continente non disponibili 134
AF - Africa 34
OC - Oceania 2
Totale 7.564
Nazione #
IT - Italia 1.942
US - Stati Uniti d'America 1.751
RU - Federazione Russa 1.126
CN - Cina 443
SG - Singapore 385
BR - Brasile 199
HK - Hong Kong 159
NL - Olanda 156
SE - Svezia 135
VN - Vietnam 129
JP - Giappone 105
DE - Germania 90
FR - Francia 79
CA - Canada 74
BD - Bangladesh 58
GB - Regno Unito 58
FI - Finlandia 50
IN - India 44
TR - Turchia 38
AR - Argentina 27
PL - Polonia 25
ES - Italia 23
AT - Austria 22
MX - Messico 18
CR - Costa Rica 14
LT - Lituania 13
CO - Colombia 11
CZ - Repubblica Ceca 11
PH - Filippine 11
ZA - Sudafrica 10
CH - Svizzera 9
BE - Belgio 8
IE - Irlanda 8
IQ - Iraq 8
NO - Norvegia 8
AE - Emirati Arabi Uniti 7
EC - Ecuador 7
GT - Guatemala 6
HN - Honduras 6
MA - Marocco 6
UA - Ucraina 6
DK - Danimarca 5
DZ - Algeria 5
JM - Giamaica 5
NI - Nicaragua 5
PE - Perù 5
PK - Pakistan 5
PT - Portogallo 5
SA - Arabia Saudita 5
TT - Trinidad e Tobago 5
VE - Venezuela 5
CL - Cile 4
GR - Grecia 4
ID - Indonesia 4
MY - Malesia 4
NP - Nepal 4
PY - Paraguay 4
TN - Tunisia 4
UY - Uruguay 4
UZ - Uzbekistan 4
BB - Barbados 3
IL - Israele 3
KE - Kenya 3
PR - Porto Rico 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CW - ???statistics.table.value.countryCode.CW??? 2
DO - Repubblica Dominicana 2
EG - Egitto 2
IR - Iran 2
KG - Kirghizistan 2
KR - Corea 2
SC - Seychelles 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BJ - Benin 1
GE - Georgia 1
GP - Guadalupe 1
HR - Croazia 1
HT - Haiti 1
HU - Ungheria 1
KH - Cambogia 1
KY - Cayman, isole 1
LB - Libano 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
SI - Slovenia 1
SN - Senegal 1
Totale 7.432
Città #
Milan 328
Ashburn 260
Singapore 224
Moscow 212
San Jose 178
Rome 156
Hong Kong 153
New York 127
Dallas 90
Shanghai 78
Beijing 74
Los Angeles 74
Council Bluffs 68
Turin 52
Hefei 43
Phoenix 43
Bologna 41
Lauterbourg 40
Florence 39
Santa Clara 39
Ho Chi Minh City 36
Verona 35
Princeton 31
Hanoi 30
Lawrence 29
Naples 29
Palermo 28
Tokyo 28
Munich 26
Genoa 25
São Paulo 25
Boardman 24
Bari 22
Frankfurt am Main 21
Helsinki 21
Brooklyn 20
Warsaw 19
Atlanta 18
Chennai 18
Chicago 18
Montreal 18
Orem 17
Turku 17
North Bergen 16
Catania 15
Trieste 14
Manchester 13
Vienna 13
Bolzano 12
Brescia 12
Guangzhou 12
Miano 12
Nuremberg 12
Amsterdam 11
Azzano San Paolo 11
Buffalo 11
Toronto 11
Denver 10
London 10
Modena 10
Stockholm 10
Ankara 9
Da Nang 9
Houston 9
Miami 9
Paris 9
Perugia 9
Bergamo 8
Columbus 8
Istanbul 8
The Dalles 8
Bursa 7
Cascina 7
Dublin 7
Falconara Marittima 7
Lamezia Terme 7
Padova 7
Pavia 7
Porto Alegre 7
Prato 7
Cesano Boscone 6
Hayamiya 6
Johannesburg 6
Lappeenranta 6
Memphis 6
Montepulciano 6
Oslo 6
Parma 6
Pesaro 6
Reggio Emilia 6
San Francisco 6
San José 6
Valencia 6
Venice 6
Andria 5
Barnet 5
Boston 5
Brasília 5
Brussels 5
Casablanca 5
Totale 3.352
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 2.151
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 274
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 177
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 164
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment 148
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 145
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 138
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 138
Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study 136
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 136
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 134
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 134
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 132
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 128
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 127
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 126
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 124
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 116
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 116
Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis 116
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 110
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 107
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 106
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 105
Radioguided Surgery for Prostate Cancer 104
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 103
Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1 102
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer 101
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies 98
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 97
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 96
The quality of life of children and adolescents with X-linked agammaglobulinemia 95
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 94
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging 91
Reply by Authors 91
Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy 87
Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation 86
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 86
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history 85
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter 79
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society 73
Metastatic hormone‑sensitive prostate cancer: local treatment strategies 72
RE: Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates 71
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter 68
Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer 66
Global Variation in Magnetic Resonance Imaging Quality of the Prostate 61
Letter - Can micro-ultrasound be the new first-choice test for patients with a suspicion of prostate cancer? 60
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy 58
The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series 55
Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes 54
Surgical Management of PSMA PET-Positive Lymph Nodes in Prostate Cancer 27
Serenoa Repens–Lycopene–Selenium and Epilobium–Palmitoylethanolamide–Calendula after transperineal prostate biopsy: a tertiary single center experience 21
Comparison of Single- and Multiport Robot-assisted Approaches in Prostate and Renal Surgery: A Systematic Review and Meta-analysis 20
Multicentre validation of the PRECISE scoring system for prostate MRI during active surveillance 19
Years of life lost and mortality rates from metastatic prostate cancer in contemporary African Americans vs. Caucasians 19
Artificial intelligence in robotic urologic surgery: a scoping review 18
PSMA Radio-guided Surgery to Identify Lymph Node Metastases in Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Phase 2 Prospective Study 17
null 1
null 1
Totale 7.564
Categoria #
all - tutte 29.136
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.136


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202298 0 0 0 8 8 7 15 14 5 10 17 14
2022/2023346 78 57 22 14 14 55 24 26 15 4 24 13
2023/2024686 12 16 37 47 50 131 43 77 11 80 78 104
2024/20251.550 186 70 119 73 105 145 207 185 165 87 91 117
2025/20263.795 252 189 155 458 355 121 305 339 988 252 170 211
2026/20271.060 244 183 239 394 0 0 0 0 0 0 0 0
Totale 7.564